Medical Sanctions and the Response of Pharmaceutical Companies to Russia’s Invasion of Ukraine: A Thematic Analysis

Pharmaceutical companies adopted a nuanced approach, balancing ethical obligations to provide essential medicines with responses to the conflict. The findings highlight the complex decision-making processes faced by multinational corporations during international conflicts, revealing a strategic response that prioritizes humanitarian needs and regulatory compliance alongside business continuity.